CORBUS PHARMACEUTICALS HOLDINGS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.25 USD | +2.24% |
|
-12.72% | +467.05% |
Chart calendar Corbus Pharmaceuticals Holdings, Inc.
26a30a8acf4e05db9e4d8cf6062.-lK5pkRy3G1MAQ-LJWSaIF9me0HgbR8B15xMwnkxCMY.ojmN6CwYtSsdcjf4URf0EyorDCPXPSpLvf4mqRVBWbeKA-DjAyGsDD0sSg~94d3b9098dc06fe1873e705339a10c7a
Upcoming events on Corbus Pharmaceuticals Holdings, Inc.
Past events on Corbus Pharmaceuticals Holdings, Inc.
| 20/03/2024 08:30 pm | BMO Capital Markets Inaugural Obesity Summit |
| 20/03/2024 | BMO Obesity Summit |
| 12/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 14/02/2024 07:10 pm | Oppenheimer Healthcare Life Sciences Conference |
| 25/01/2024 | ASCO Genitourinary Cancers Symposium |
| 03/01/2024 | Investor Meeting |
| 07/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract No:1388 |
| 14/10/2023 10:00 pm | AACR-NCI-EORTC International Conference |
| 08/08/2023 06:30 pm | BTIG Virtual Biotechnology Conference |
| 08/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 08/06/2023 12:30 am | Jefferies Global Healthcare Conference |
| 18/05/2023 05:30 pm | Annual General Meeting |
| 09/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 04/05/2023 02:00 am | New York Academy of Sciences Frontiers in Cancer Immunotherapy Meeting |
| 16/04/2023 11:00 pm | American Association for Cancer Research Meeting |
| 14/03/2023 06:50 pm | Oppenheimer Healthcare Conference |
| 07/03/2023 06:30 pm | Q4 2022 Earnings Release |
| 20/12/2022 07:30 pm | Extraordinary Shareholders Meeting |
| 11/11/2022 06:00 am | Society for Immunotherapy of Cancer Meeting - Poster #815 |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 36,1 37,9 -4.74% | 3,94 4,77 -17.52% | 0,88 0,84 5.03% | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -77,1 -72,4 -6.45% | -123 -123 0.26% | -56,0 -60,0 6.71% | -39,8 -38,6 -3.15% | -45,1 -45,1 -0% | -52,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -71,5 -68,6 -4.18% | -111 -125 10.63% | -45,6 -49,8 8.41% | -42,3 -39,8 -6.47% | -44,6 -47,0 5.2% | -53,5 |
|
Net income Million USD | Released Forecast Spread | -71,5 -69,0 -3.57% | -111 -122 8.9% | -45,6 -49,8 8.41% | -42,3 -39,8 -6.47% | -44,6 -47,0 5.2% | -53,5 |
|
EPS USD | Released Forecast Spread | -33,6 -32,2 -4.43% | -42,6 -47,6 10.55% | -11,1 -12,1 8.26% | -10,2 -9,50 -6.84% | -10,3 -10,9 5.06% | -5,21 |
| Announcement Date | 12/03/20 | 15/03/21 | 08/03/22 | 07/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,17 - | 0,00 0,08 - | 0,00 0,10 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -10,00 -13,8 27.63% | -8,52 -12,1 29.54% | -12,3 -8,67 -42.3% | -8,18 -7,82 -4.68% | -10,8 -9,58 -12.72% | -17,3 -9,10 -90.08% | -8,19 -12,5 34.49% | -9,49 -8,20 -15.71% | -10,1 -10,1 -0.14% | -10,9 | -12,2 | -13,9 | -15,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -10,3 -14,1 27.05% | -9,44 -10,8 12.95% | -13,2 -7,43 -78.41% | -8,78 -6,57 -33.66% | -10,9 -8,84 -23.04% | -17,7 -17,3 -2.87% | -8,78 -13,2 33.46% | -10,1 -8,80 -14.24% | -8,02 -10,5 23.73% | -11,1 | -12,4 | -14,1 | -15,9 |
|
Net income Million USD | Released Forecast Spread | -10,3 -14,1 27.05% | -9,44 -10,8 12.95% | -13,2 -7,43 -78.41% | -8,78 -6,57 -33.66% | -10,9 -8,84 -23.04% | -17,7 -17,3 -2.87% | -8,78 -13,2 33.46% | -10,1 -8,80 -14.24% | -8,02 -10,5 23.73% | -11,1 | -12,4 | -14,1 | -15,9 |
|
EPS USD | Released Forecast Spread | -2,40 -3,20 25% | -2,40 -2,55 5.88% | -3,30 -1,80 -83.33% | -2,10 -1,65 -27.27% | -2,61 -2,10 -24.29% | -4,24 -4,09 -3.67% | -2,05 -3,10 33.87% | -2,27 -2,06 -10.19% | -1,81 -2,36 23.31% | -1,09 | -1,21 | -1,37 | -1,53 |
| Announcement Date | 08/03/22 | 10/05/22 | 09/08/22 | 08/11/22 | 07/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 12/03/24 | - | - | - | - |
More events
Past sector events for Corbus Pharmaceuticals Holdings, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CRBP Stock
- Calendar Corbus Pharmaceuticals Holdings, Inc.
